Endo Par Innovation Company, LLC

Member Case
Lead case is: 7:22-bk-22549

New York Southern Bankruptcy Court
Chapter 11
Judge:James L Garrity Jr
Case #: 7:22-bk-22561
Case Filed:Aug 16, 2022

TypeCorporation
Tax IDsubscribers only
# of Creditors10,001-25,000
Est. Assets$1,000,000,001 to $10 billion
Est. Liabilities $1,000,000,001 to $10 billion
Nature of Business Other
Nature of Debts Primarily Business

Debtor
Endo Par Innovation Company, LLC
6 Ram Ridge Rd
Chestnut Ridge, NY 10977-6713
Represented By
Paul D. Leake
Skadden, Arps, Slate, Meagher & Flom LLP
contact info
Last checked: never
U.S. Trustee
United States Trustee
Office of the United States Trustee U.S. Federal Office Building 201 Varick Street, Room 1006
New York, NY 10014


Docket last updated: 38 minutes ago
Friday, June 28, 2024
18 18 misc Chapter 11 Monthly Operating Report UST Form 11-MOR Fri 06/28 9:37 AM
Chapter 11 Monthly Operating Report for the Month Ending: 03/31/2024 Filed by Catherine V. LoTempio on behalf of Endo Par Innovation Company, LLC. (LoTempio, Catherine)
Related: [-]
Tuesday, June 25, 2024
17 17 misc Chapter 11 Monthly Operating Report UST Form 11-MOR Tue 06/25 9:12 PM
Chapter 11 Monthly Operating Report for Case Number 22-22549 for the Month Ending: 03/31/2024 Filed by Catherine V. LoTempio on behalf of Endo Par Innovation Company, LLC. (LoTempio, Catherine)
Related: [-]
Wednesday, April 26, 2023
16 16 misc Amended Schedules Wed 04/26 1:50 PM
Amended Schedules filed: Schedule A/B - Non-Individual, Schedule E/F - Non-Individual Filed by Kyle J. Ortiz on behalf of Endo Par Innovation Company, LLC. (Ortiz, Kyle)
Related: [-]
crditcrd Auto - docket of credit card Wed 04/26 4:07 PM
Receipt of Amended Schedules([LINK 22-22561 jlg] ) [misc,schaja] ( 32.00) Filing Fee. Receipt number A16178940. Fee amount 32.00. Related [+] (U.S. Treasury)
Related: [-] Doc #16
Saturday, March 18, 2023
misc Terminate Pending Deadlines Sat 03/18 11:05 PM
Pending Deadlines Terminated: All Schedules and Statements. (Rodriguez, Willie)
Related: [-]
Friday, March 03, 2023
15 15 misc Disclosure of Compensation of Attorney For Debtor (Rule 2016(b)) - Form 2030 (batch) Fri 03/03 1:54 PM
Disclosure of Compensation of Attorney For Debtor (Rule 2016(b))- Form 2030 (Leake, Paul)
Related: [-]
Thursday, November 17, 2022
14 14 order Motion, Extend Deadline to File Schedules Thu 11/17 9:56 AM
Order signed on 11/16/2022 Granting Motion To Extend Deadline to File Schedules or Provide Required Information: DEADLINE: 11/30/2022 Related [+] (Rodriguez, Willie)
Related: [-] 11
Thursday, November 10, 2022
13 13 misc Statement of Financial Affairs Thu 11/10 2:45 PM
Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Endo Par Innovation Company, LLC Filed by Kyle J. Ortiz on behalf of Endo Par Innovation Company, LLC. (Ortiz, Kyle)
Related: [-]
12 12 misc Schedules Thu 11/10 2:43 PM
Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes, Summary and Schedules of Assets and Liabilities for Endo Par Innovation Company, LLC Filed by Kyle J. Ortiz on behalf of Endo Par Innovation Company, LLC. (Ortiz, Kyle)
Related: [-]
Thursday, October 27, 2022
11 11 motion Motion, Extend Deadline to File Schedules Thu 10/27 2:43 PM
Motion to Extend Deadline to File Schedules or Provide Required Information /(Hearing Date: 11/10/2022 at 11:00 AM, Objections Due: 11/3/2022 at 4:00 PM) Notice of Hearing and Motion of Debtors for Entry of an Order Further Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs (Attachment: Exhibit A: Proposed Order) filed by Kyle J. Ortiz on behalf of Endo Par Innovation Company, LLC with hearing to be held on 11/10/2022 at 11:00 AM at Videoconference (ZoomGov) (JLG) Objections due by 11/3/2022,. (Ortiz, Kyle)
Related: [-]
Tuesday, October 25, 2022
10 10 order Motion, Extend Deadline to File Schedules Tue 10/25 10:11 AM
Order signed on 10/24/2022 Granting Motion To Extend Deadline to File Schedules or Provide Required Information. Deadline: 10/31/2022 Related [+] (Rodriguez, Willie)
Related: [-] 9
Tuesday, September 27, 2022
9 9 motion Motion, Extend Deadline to File Schedules Tue 09/27 3:39 PM
Motion to Extend Deadline to File Schedules or Provide Required Information /(Hearing Date: October 13, 2022 at 11:00 a.m., Objection Deadline: October 6, 2022 at 4:00 p.m.) Notice of Hearing and Motion of Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs filed by Kyle J. Ortiz on behalf of Endo Par Innovation Company, LLC with hearing to be held on 10/13/2022 at 11:00 AM at Videoconference (ZoomGov) (JLG) Objections due by 10/6/2022,. (Ortiz, Kyle)
Related: [-]
Monday, September 12, 2022
misc Add Party Mon 09/12 10:08 AM
Party Kroll Restructuring Administration LLC Claims Agent added to the case.. (Rodriguez, Willie)
Related: [-]
Friday, September 09, 2022
8 8 6 pgs order Order Re: Motion, Appoint Claims and Noticing Agent Fri 09/09 10:07 AM
Order signed on 9/6/2022 Granting Motion Appointing Kroll Restructuring Administration LLC as Claims and Noticing Agent. Related [+] (Rodriguez, Willie)
Related: [-] 6
Thursday, August 25, 2022
7 7 order Motion, Extend Deadline to File Schedules Thu 08/25 4:29 PM
Order signed on 8/23/2022 Granting Motion To Extend Deadline to File Schedules or Provide Required Information. Deadline: 9/29/2022 Related [+] (Rodriguez, Willie)
Related: [-] 3
Sunday, August 21, 2022
misc Set Deficiency Deadlines Sun 08/21 9:56 AM
Deficiencies Set: Schedule A/B due 8/30/2022. Schedule D due 8/30/2022. Schedule E/F due 8/30/2022. Schedule G due 8/30/2022. Schedule H due 8/30/2022. Summary of Assets and Liabilities due 8/30/2022. Statement of Financial Affairs due 8/30/2022. Atty Disclosure State. due 8/30/2022. List of all creditors due 8/30/2022. List of All Creditors Required on Case Docket in PDF Format due 8/30/2022. Incomplete Filings due by 8/30/2022, (Rodriguez, Willie)
Related: [-]
Thursday, August 18, 2022
6 6 motion Motion, Appoint Claims and Noticing Agent Thu 08/18 7:39 PM
Motion to Appoint Kroll Restructuring Administration LLC as Claims and Noticing Agent /Application of the Debtors for an Order (I) Appointing Kroll Restructuring Administration LLC as Claims and Noticing Agent Nunc Pro Tunc to the Petition Date; and (II) Granting Related Relief filed by Paul D. Leake on behalf of Endo Par Innovation Company, LLC. (Leake, Paul)
Related: [-]
misc Case Association - Joint Administration Thu 08/18 4:22 PM
Case Jointly Administered with 22-22549 (Rodriguez, Willie)
Related: [-]
Wednesday, August 17, 2022
5 5 order Motion, Joint Administration Wed 08/17 6:53 PM
Order signed on 8/17/2022 in accordance with Rule 1015(b) of the Federal Rules of Bankruptcy Procedure directing the procedural consolidation and joint administration of the chapter 11 cases of Endo International plc and its affiliates that have concurrently commenced chapter 11 cases. The docket in the chapter 11 case of Endo International plc (3755), Case No. 22-22549 (JLG), should be consulted for all matters affecting the chapter 11 cases of : 70 Maple Avenue, LLC (1491); Actient Pharmaceuticals LLC (7232); Actient Therapeutics LLC (2019); Anchen Incorporated (8760); Anchen Pharmaceuticals, Inc. (9179); Astora Womens Health Ireland Limited (5829); Astora Womens Health, LLC (0427); Auxilium International Holdings, LLC (9643); Auxilium Pharmaceuticals, LLC (6883); Auxilium US Holdings, LLC (8967); Bermuda Acquisition Management Limited (N/A); BioSpecifics Technologies LLC (4851); Branded Operations Holdings, Inc. (6945); DAVA International, LLC (9945); DAVA Pharmaceuticals, LLC (7354); Endo Aesthetics LLC (0218); Endo Bermuda Finance Limited (4093); Endo Designated Activity Company (7135); Endo Eurofin Unlimited Company (2009); Endo Finance IV Unlimited Company (2779); Endo Finance LLC (6481); Endo Finance Operations LLC (6355); Endo Finco Inc. (5794); Endo Generics Holdings, Inc. (4834); Endo Global Aesthetics Limited (2898); Endo Global Biologics Limited (2735); Endo Global Development Limited (4785); Endo Global Finance LLC (7754); Endo Global Ventures (4244); Endo Health Solutions Inc. (2871); Endo Innovation Valera, LLC (3622); Endo Ireland Finance II Limited (0535); Endo LLC (6640); Endo Luxembourg Finance Company I S. r.l. (3863); Endo Luxembourg Holding Company S..r.l. (7168); Endo Luxembourg International Financing S..r.l. (2905); Endo Management Limited (4866); Endo Par Innovation Company, LLC (2435); Endo Pharmaceuticals Finance LLC (5768); Endo Pharmaceuticals Inc. (5829); Endo Pharmaceuticals Solutions Inc. (7911); Endo Pharmaceuticals Valera Inc. (9931); Endo Procurement Operations Limited (7840); Endo TopFin Limited (8086); Endo U.S. Inc. (0786); Endo US Holdings Luxembourg I S..r.l. (7910); Endo Ventures Aesthetics Limited (9967); Endo Ventures Bermuda Limited (0688); Endo Ventures Cyprus Limited (1544); Endo Ventures Limited (6029); Generics Bidco I, LLC (6905); Generics International (US) 2, Inc. (5075); Generics International (US), Inc. (6489); Generics International Ventures Enterprises LLC (4685); Hawk Acquisition Ireland Limited (4776); Innoteq, Inc. (3381); JHP Acquisition, LLC (7861); JHP Group Holdings, LLC (7688); Kali Laboratories 2, Inc. (6751); Kali Laboratories, LLC (4898); Luxembourg Endo Specialty Pharmaceuticals Holding I S. r.l. (0601); Moores Mill Properties L.L.C. (9523); Paladin Labs Canadian Holding Inc. (N/A); Paladin Labs Inc. (1410); Par Laboratories Europe, Ltd. (9597); Par Pharmaceutical 2, Inc. (4895); Par Pharmaceutical Companies, Inc. (8301); Par Pharmaceutical Holdings, Inc. (3135); Par Pharmaceutical, Inc. (8342); Par Sterile Products, LLC (0105); Par, LLC (1286); Quartz Specialty Pharmaceuticals, LLC (5368); Slate Pharmaceuticals, LLC (6201); Timm Medical Holdings, LLC (8744); and Vintage Pharmaceuticals, LLC (7882). Related [+] (Rodriguez, Willie)
Related: [-] 2
4 4 misc Affidavit Pursuant to LR 1007-2 Wed 08/17 5:58 PM
Affidavit Pursuant to LR 1007-2 /Declaration of Mark Bradley in Support of Chapter 11 Petitions and First Day Papers Filed by Paul D. Leake on behalf of Endo Par Innovation Company, LLC. (Leake, Paul)
Related: [-]
3 3 motion Motion, Extend Deadline to File Schedules Wed 08/17 9:56 AM
Motion to Extend Deadline to File Schedules or Provide Required Information /Motion of the Debtors for Entry of an Order (I) Extending the Time to File Schedules and Statements of Financial Affairs; (II) Extending the Time to File Reports of Financial Information Required Under Bankruptcy Rule 2015.3; (III) Waiving Requirement to File List of Equity Security Holders and Provide Notice of Commencement to Equity Security Holders; and (IV) Granting Related Relief filed by Paul D. Leake on behalf of Endo Par Innovation Company, LLC. (Leake, Paul)
Related: [-]
2 2 motion Motion, Joint Administration Wed 08/17 12:14 AM
Motion for Joint Administration //Motion of the Debtors for Entry of an Order (I) Directing Joint Administration of the Chapter 11 Cases Pursuant to Bankruptcy Rule 1015(b); (II) Waiving the Requirements of Section 342(c)(1) of the Bankruptcy Code and Bankruptcy Rule 2002(n); and (III) Granting Related Relief filed by Paul D. Leake on behalf of Endo Par Innovation Company, LLC. (Leake, Paul)
Related: [-]
misc Add Judge Wed 08/17 8:44 AM
Judge James L. Garrity, Jr. added to the case. (Cappiello, Karen)
Related: [-]
Tuesday, August 16, 2022
1 1 23 pgs misc Voluntary Petition (Chapter 11) Tue 08/16 10:15 PM
Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Case Designated As Mega as per LBR 1073-1. Chapter 11 Plan due by 12/14/2022, Disclosure Statement due by 12/14/2022, Initial Case Conference due by 9/15/2022, Filed by Paul D. Leake of Skadden, Arps, Slate, Meagher & Flom LLP on behalf of Endo Par Innovation Company, LLC. (Leake, Paul)
Related: [-]
crditcrd Auto - docket of credit card Tue 08/16 11:25 PM
Receipt of Voluntary Petition (Chapter 11)([LINK 22-22561 ) [misc,824] (1738.00) Filing Fee. Receipt number A15881001. Fee amount 1738.00. Related [+] (U.S. Treasury)
Related: [-] Doc #1